Massachusetts General Hospital Logo

Neuroendocrine and Pituitary
Tumor Clinical Center (NEPTCC) Bulletin

Winter 2017/2018 | Volume 24, Issue 1

Services Available

Facilities

The Neuroendocrine and Pituitary Tumor Clinical Center is located on the 1st floor (Suite 140) of the Cox Building at the Massachusetts General Hospital. A test center is available for complete outpatient diagnostic testing, including ACTH (Cortrosyn) stimulation; insulin tolerance; CRH stimulation; oral glucose tolerance and growth hormone stimulation testing. Testing for Cushing’s syndrome can also be arranged, including bilateral inferior petrosal sinus ACTH sampling for patients with ACTH-dependent Cushing’s syndrome.

 

Neuroendocrine and Pituitary Tumor Clinical Conference

A weekly interdisciplinary conference is held to discuss all new patients referred to the Center and to review patient management issues. It is a multidisciplinary conference, attended by members of the Neuroendocrine, Neurology, Neurosurgery, Psychiatry and Radiation Oncology services. Physicians are welcome to attend and present cases.

 

Physicians’ Pituitary Information Service (PPIS)

Physicians with questions about pituitary disorders may contact the PPIS at (617) 726-3965 within the Boston area or toll free at (888) 429-6863, or e-mail to pituitary.info@partners.org.

 

Scheduling

Outpatient clinical consultations can be arranged by calling the Neuroendocrine and Pituitary Tumor Clinical Center Office at (617) 726-7948.

 

Acknowledgements

The MGH Neuroendocrine and Pituitary Tumor Clinical Center Bulletin was supported in part by unrestricted educational grants from HRA Pharma, Ascendis Pharma and Strongbridge. Other financial relationships may exist between these companies and The Massachusetts General Hospital.

Dr. Beverly MK Biller, Editor of the MGH Neuroendocrine and Pituitary Tumor Clinical Center Bulletin, is the primary investigator on research grants to the Neuroendocrine Unit from NovoNordisk and Novartis and occasionally consults for Ferring, Merck-Serono, Novartis, NovoNordisk, Pfizer and Sandoz.

 

MGH Neuroendocrine and Pituitary Tumor Clinical Center Bulletin

Massachusetts General Hospital
100 Blossom Street, Cox 140
Boston, Massachusetts  02114

Supervising Staff

 

Endocrinology:

Anne Klibanski, MD
Chief, Neuroendocrine Unit

Karen K Miller, MD
Center Clinical Co-Director

Lisa Nachtigall, MD
Center Clinical Co-Director

Beverly MK Biller, MD

Laura Dichtel, MD

Alex Faje, MD

Pouneh Fazeli, MD

Steven Grinspoon, MD

Elizabeth Lawson, MD

Janet Lo, MD

Melanie Schorr, MD

Suman Srinivasa, MD

Nicholas Tritos, MD, DSc

Markella Zanni, MD

 

Neurology:

Thomas N Byrne, MD

 

Neurosurgery:

Brooke Swearingen, MD

Pamela S. Jones, MD

Nicholas T Zervas, MD (emeritus)

 

Radiation Oncology:

Jay S Loeffler, MD
Chief, Radiation Oncology

Helen A Shih, MD

 

Psychiatry:

Gregory L Fricchione, MD

Ana Ivkovic, MD

 

Pediatric Endocrinology:

Madhusmita Misra, MD, MPH

Takara L Stanley, MD

.

.

.